cytarabine has been researched along with Leukoencephalopathy Syndrome, Posterior in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morgensztern, D; Peddi, PF; Peddi, S; Santos, ES | 1 |
| Bingo, M; Hayashi, Y; Hino, M; Koh, H; Nakamae, H; Nakane, T; Nanno, S; Nishimoto, M; Shimono, T; Yoshida, M | 1 |
| Avilia, S; Battipaglia, G; Camera, A; Caranci, F; Morelli, E; Perna, F | 1 |
1 review(s) available for cytarabine and Leukoencephalopathy Syndrome, Posterior
| Article | Year |
|---|---|
Central nervous system toxicities of chemotherapeutic agents.
Topics: Antineoplastic Agents; Central Nervous System Diseases; Cisplatin; Cytarabine; Fluorouracil; Humans; Ifosfamide; Methotrexate; Neurotoxicity Syndromes; Posterior Leukoencephalopathy Syndrome; Vidarabine; Vincristine | 2014 |
2 other study(ies) available for cytarabine and Leukoencephalopathy Syndrome, Posterior
| Article | Year |
|---|---|
Posterior reversible encephalopathy syndrome following acute pancreatitis during chemotherapy for acute monocytic leukemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Humans; Leukemia, Monocytic, Acute; Male; Methylprednisolone; Pancreatitis; Posterior Leukoencephalopathy Syndrome | 2014 |
Posterior reversible encephalopathy syndrome (PRES) during induction chemotherapy for acute myeloblastic leukemia (AML).
Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Etoposide; Female; Humans; Induction Chemotherapy; Leukemia, Myeloid, Acute; Middle Aged; Posterior Leukoencephalopathy Syndrome; Young Adult | 2012 |